These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28594056)

  • 1. The effect of add-on memantine on positive, negative and depressive symptoms of schizophrenia: a doubleblind, randomized, controlled trial.
    Omranifard V; Rajabi F; Mohammadian-Sichani M; Maracy MR
    Actas Esp Psiquiatr; 2017 May; 45(3):108-15. PubMed ID: 28594056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
    Lieberman JA; Papadakis K; Csernansky J; Litman R; Volavka J; Jia XD; Gage A;
    Neuropsychopharmacology; 2009 Apr; 34(5):1322-9. PubMed ID: 19005465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
    Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
    J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.
    Kishi T; Matsuda Y; Iwata N
    Psychopharmacology (Berl); 2017 Jul; 234(14):2113-2125. PubMed ID: 28508107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
    Veerman SR; Schulte PF; Deijen JB; de Haan L
    Psychol Med; 2017 Jan; 47(2):363-375. PubMed ID: 27776560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
    Schaefer M; Sarkar S; Theophil I; Leopold K; Heinz A; Gallinat J
    Pharmacopsychiatry; 2020 Jan; 53(1):21-29. PubMed ID: 31390660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis.
    Vayısoğlu S; Karahan S; Anıl Yağcıoğlu AE
    Turk Psikiyatri Derg; 2019; 30(4):253-259. PubMed ID: 32594486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.
    Veerman SR; Schulte PF; Smith JD; de Haan L
    Psychol Med; 2016 Jul; 46(9):1909-21. PubMed ID: 27048954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial.
    Mazinani R; Nejati S; Khodaei M
    Psychiatry Res; 2017 Jan; 247():291-295. PubMed ID: 27940324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive Memantine Treatment of Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Study.
    Hassanpour F; Zarghami M; Mouodi S; Moosazadeh M; Barzegar F; Bagheri M; Hendouei N
    J Clin Psychopharmacol; 2019; 39(6):634-638. PubMed ID: 31688396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
    Terevnikov V; Stenberg JH; Tiihonen J; Joffe M; Burkin M; Tchoukhine E; Joffe G
    Hum Psychopharmacol; 2011 Apr; 26(3):188-93. PubMed ID: 21469215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
    Khodaie-Ardakani MR; Seddighi S; Modabbernia A; Rezaei F; Salehi B; Ashrafi M; Shams-Alizadeh N; Mohammad-Karimi M; Esfandiari GR; Hajiaghaee R; Akhondzadeh S
    J Psychiatr Res; 2013 Apr; 47(4):472-8. PubMed ID: 23375406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-Arginine Add-On Treatment for Schizophrenia: A Randomized,Double-Blind, Placebo-Controlled, Crossover Study].
    Koçyiğit Y; Yoca G; Karahan S; Ayhan Y; Yazıcı MK
    Turk Psikiyatri Derg; 2018; 29(3):147-153. PubMed ID: 30260460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials.
    Zheng W; Zhu XM; Zhang QE; Cai DB; Yang XH; Zhou YL; Ungvari GS; Ng CH; He SH; Peng XJ; Ning YP; Xiang YT
    Schizophr Res; 2019 Jul; 209():12-21. PubMed ID: 31164254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial.
    Ritsner MS; Bawakny H; Kreinin A
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):432-40. PubMed ID: 24548129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
    Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.